AVITA Medical, Inc. — Form 8-K Summary
Business context and reporting period
AVITA Medical, Inc. filed a Current Report on Form 8-K dated January 19, 2023, under Item 5.02, Item 7.01, and Item 9.01. The filing reports changes to the company’s management structure and does not provide financial results for a reporting period.
Financial metrics and liquidity
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-financial metrics.
Material changes
- Michael Holder, Chief Financial Officer, left the organization effective January 19, 2023.
- Kathy McGee, Chief Operating Officer, also left the organization.
- The company is discontinuing the Chief Operating Officer role under its new management structure.
- Sean Ekins, previously Senior Vice President of Finance, became Interim Chief Financial Officer and assumed the principal financial officer and principal accounting officer responsibilities effective immediately.
- Mr. Ekins, age 48, previously served as a controller with Ixia, a division of Keysight Technologies, Inc. The filing states that he has no reportable family relationships or related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
Compensation, outlook, risks, and unusual items
- Mr. Holder and Ms. McGee are eligible for severance under their executive employment agreements for involuntary termination without cause, subject to signing separation and release agreements.
- Severance includes 12 months of base salary, including the applicable notice-period salary; health, vision, and dental benefits for nine months after termination; and acceleration of unvested stock awards.
- Ms. McGee will also receive her 2022 annual bonus of $164,140.
- The filing provides no financial guidance or broader business outlook. The management transition, executive severance obligations, and interim CFO appointment are the principal unusual items disclosed.
- A January 19, 2023 press release announcing the management changes was furnished as Exhibit 99.1. The press release is not considered filed for Exchange Act purposes or incorporated by reference, except where expressly referenced.
Key facts for investors to verify
- Timing and execution of the CFO transition to Sean Ekins and the scope of his interim mandate.
- Total cash, benefits, equity acceleration, and other costs associated with the departures of Mr. Holder and Ms. McGee.
- Whether and when the company appoints a permanent Chief Financial Officer.
- Operational effects of eliminating the Chief Operating Officer role.
- Any subsequent filings providing updated financial results, liquidity information, or guidance.